About Us

Anthony J. Hubbard, Executive Vice President and CFO. Mr. Hubbard has provided executive, financial, and accounting services to founding management teams. He has served in an executive capacity as the Vice President of Finance, Chief Financial Officer, and General Manager for these companies. Prior to his most recent assignment, he managed business development as a general partner in a small business-consulting firm and served as a CFO of an emerging biotechnology venture from 1999 to 2002. He was a partner in a CPA firm that provided business, management and tax advisory services to entrepreneurial enterprises. Prior to joining a CPA firm in Indianapolis he co-founded and held the position of CEO for a biotechnology company for six years. He has served on the Board of Directors of a medical device industry trade association and various community groups. Mr. Hubbard is a licensed CPA and has earned a B.A. degree in Microbiology and Biological Sciences, as well as a MBA in Finance from Indiana University Kelly School of Business.

Mark A. Suckow, D.V.M., Chief Scientific Officer. Mark A. Suckow is Director of the Freimann Life Science Center and Associate Research Professor of Biological Sciences at the University of Notre Dame in Notre Dame, IN. Dr. Suckow earned the degree of Doctor of Veterinary Medicine from the University of Wisconsin in 1987, and completed a post-doctoral residency program in laboratory animal medicine at the University of Michigan in 1990. He is a Diplomate of the American College of Laboratory Animal Medicine (ACLAM). Dr. Suckow has published over 80 scientific papers, books, and book chapters. In addition, he co-edited The IACUC Handbook (CRC Press, 2000 and 2007) and The Laboratory Rat (Elsevier Academic Press, 2006). Dr. Suckow’s research focuses on cancer vaccines and vaccine adjuvants, and he has extensive experience with rodent models of cancer. Dr. Suckow served as 2006 President of the American Association for Laboratory Animal Science (AALAS) and is currently on the Board of Directors of the American Society of Laboratory Animal Practitioners (ASLAP). He was honored as the 1996 Young Investigator of the Year by the American Association for Laboratory Animal Science, and in 1998 he received the Excellence in Research Award from the American Society of Laboratory Animal Practitioners.

Paul J. Hall, Senior Scientific Advisor. Mr. Hall has nearly 25 years of experience as a research scientist and entrepreneur. He received a B.S. degree in chemistry/biology from Indiana University in 1979 and has completed graduate level coursework in immunology, pharmacology, and biochemistry. He was a research associate in the Department of Pharmacology and Toxicology at the Indiana University School of Medicine from 1982-1988. He founded Integrated Biotechnology Corp. in Carmel, Indiana in 1989 and directed the research and development of vaccines for the prevention of Respiratory Syncytial Virus (RSV) and commercialized a rapid diagnostic test for RSV that is now being marketed worldwide by Inverness Medical Innovations. Subsequently, Mr. Hall was a principle scientist at Cook Biotech Inc. conducting research and development of Extracellular Matrix (ECM) for numerous applications in tissue engineering and vaccine adjuvant formulations.

Rae D. Record Ritchie, Ph.D., Senior Scientist. Dr. Ritchie has more than 25 years experience in clinical and research laboratories. She has been the lead investigator on grants and research contracts and her research has resulted in over 25 peer-reviewed articles. Her administrative experience includes establishing and maintaining a genetic tissue bank, managing a multi-user facility, and overseeing testing agreements. Dr. Ritchie has over 6 years experience working with the base material comprising the ECM Adjuvant resulting in one patent and numerous publications. Dr. Ritchie received her B.S degree from Purdue University in Biomedical Technology and her Ph.D. from Texas A&M University in Biology.

Amy M. Overby, Vice President of Research Innovation. Mrs. Overby has more than 15 years of experience in the clinical and medical field. Mrs. Overby received her B.S. degree in molecular biology, biochemistry, and bioinformatics from Towson University and worked in cancer cytogenetics at The Johns Hopkins University School of Medicine prior to joining the research department at Cook Biotech, Inc. in 2005. At Cook Biotech, Inc. she was the principal scientist for novel and ECM based technologies from research phases to development/manufacturing transfer, including initiating and implementing extensive in vitro and in vivo studies within industries and universities. She managed undergraduate students, interns, medical students and support staff with experimental techniques and laboratory protocols/procedures as well as establishing and maintaining the biochemistry laboratory.

Katie L. Harrigan, Vice President of New Product Development. Ms. Harrigan received her B.S. and M.S. degrees in biomedical engineering from Rose-Hulman Institute of Technology before joining Cook Biotech, Inc. in 2006. Ms. Harrigan’s experience has been primarily in tissue engineering with an emphasis in collagen based materials. In her time at Cook Biotech, she developed and managed projects which provided experience in designing and manufacturing medical devices for unique applications. At the University of Illinois at Chicago, her work in the Neural Device Engineering lab aided in the development of neural tissue prosthesis using Bio-MEMS techniques. She has had the opportunity to mentor several undergraduate students on device and experimental design.